Results 241 to 250 of about 207,050 (299)

SMURF1 Regulates CTCF‐HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma

Cancer Science, EarlyView.
Our study showed that SMURF1 was significantly upregulated in nasopharyngeal carcinoma (NPC) and promoted tumor progression and SMURF1 promoted K48‐linked ubiquitination degradation of CTCF. ABSTRACT The aberrant upregulation of Homeobox A10 (HOXA10) has been implicated in the progression of nasopharyngeal carcinoma (NPC), but the mechanisms driving ...
Ying Jin, Tian Zhang, Zhimin Wu, Yuanshan Liang, Yiting Jiang, Guodong Yu   +5 more
wiley   +1 more source

Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Kunte SC, Holzgreve A, Unterrainer M, Zahner J, Schmid HP, Schöll M, Blajan I, Sheikh GT, Mehrens D, Casuscelli J, Tamalunas AJ, Werner RA, Stief CG, Staehler M, Unterrainer LM.   +14 more
europepmc   +1 more source

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy

Cancer Science, EarlyView.
Early screening for somatic alterations in localized prostate cancer could help predict biochemical recurrence risk and optimize salvage therapy selection. ABSTRACT The clinical significance of comprehensive genomic profiling (CGP) has been established in metastatic castration‐resistant prostate cancer (PC).
Kenji Zennami, Tetsuya Takimoto, Takuhisa Nukaya, Makoto Sumitomo, Mayu Takeda, Eiji Sugihara, Hideyuki Saya, Ryoichi Shiroki   +7 more
wiley   +1 more source

Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography. [PDF]

Transl Androl Urol
Gonzalez Del Portillo E, López-Campos F, Sargos P, Couñago F.   +3 more
europepmc   +1 more source

Prostate‐specific membrane antigen (PSMA)‐PET‐avid prostate cancers show stronger PSMA immunohistochemistry staining on biopsy cores

BJU International, EarlyView.
Jonathon Carll, Henry Yen‐Cheng Pan, Nathan Lawrentschuk, Andrew Ryan   +3 more
wiley   +1 more source

Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study). [PDF]

EJNMMI Res
Binzaqr S, Kryza D, Giraudet AL, Bernhard JC, Gross-Goupil M, Yacoub M, Margue G, Hindié E, Morgat C.   +8 more
europepmc   +1 more source

Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International Survey. [PDF]

Eur Urol Open Sci
Zattoni F, Rajwa P, Kasivisvanathan V, Sanchez LR, Fazekas T, Preisser F, Kesch C, Martini A, Reitano G, Sigle A, Olivier J, Nicoletti R, Bernardino R, Heidegger I, Bianchi L, Bauckneht M, Giganti F, Giesen A, Soeterik T, van den Bergh R, Rivas JG, Dal Moro F, Russo GI, Gandaglia G, Marra G.   +24 more
europepmc   +1 more source

Prostate-Specific Membrane Antigen-Targeted Imaging and Its Correlation with HOXB13 Expression. [PDF]

J Nucl Med
Angappulige DH, Barashi NS, Pickersgill N, Weimholt C, Luo J, Shadmani G, Tarcha Z, Rayamajhi S, Mahajan NP, Andriole GL, Siegel BA, Kim EH, Mahajan K.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prostate-specific membrane antigen

The Prostate, 1997
In an effort to discover new prostate-specific antigens (PSAs) to enhance our understanding of the functions and behavior of the prostate and the complex processes involved in prostate tumor progression, the structure and function of the PSM antigen has been elucidated.The PSM antigen was recognized using the 7E11-C5.3 monoclonal antibody, generated ...
W R, Fair, R S, Israeli, W D, Heston
openaire   +3 more sources